BIOA (BioAge Labs, Inc) Total Nilai Perusahaan

BioAge Labs, Inc. (BIOA) ensures production stability by establishing an extensive component supply chain. Simultaneously, the company is researching aging processes to develop therapies for metabolic disorders. This price chart shows that the company's valuation is -64.86. The technology stack is further enhanced by the implementation of robotic systems and AI services for the precise identification of molecular targets.

BIOA (bioagelabs.com) riwayat Nilai Total Perusahaan saka 23.11.2025 nganti 28.10.2026

BioAge Labs, Inc. (BIOA) - rincian metrik lan laporan keuangan

- rega lan prakiraan konsensus rega:

Bagan bursa BioAge Labs|BIOA - Bagan rega target

- data kapitalisasi pasar:

Nilai pasar BioAge Labs, Inc.|BIOA - Nilai Perusahaan

- data kapitalisasi buku:

Nilai Buku saben Saham BioAge Labs, Inc.|BIOA - Nilai Buku Perusahaan|Kapitalisasi Pasar marang Aset Bersih bioagelabs.com|BIOA - Total Aset Perusahaan

- data utang lan likuiditas:

Rasio Kabeh Utang marang Dana Pribadi BioAge Labs, Inc.|BIOA - Utang jangka dawa marang modal|Utang jangka cendhak marang modal bioagelabs.com|BIOA - Utang perusahaan|Rasio utang marang aset resik BioAge Labs, Inc.|BIOA - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan BioAge Labs, Inc.

Analisis komprehensif perusahaan:BioAge Labs (BIOA)

BioAge Labs, Inc. (BIOA) development of incretin mimetics and its partnership with Eli Lilly position the company as a strategic asset in the longevity sector. The current market valuation of assets, excluding liquidity, at -64.86, aggregates capitalization and net debt to determine the actual business buyout value. The dynamics of this indicator allow investors to assess the stability of the company's capital relative to its fundamental value amid volatility.

Analisis pesaing BioAge Labs, Inc.

Ascendis Pharma AS - Rega Tumbas Perusahaan|MDGL (Madrigal Pharma) - Nilai Total Perusahaan|CORT - Total Nilai Perusahaan|RYTM: Nilai Perusahaan|AKRO (akerotx.com) - Nilai Perusahaan|Nilai Total Perusahaan Metsera MTSR|Nilai Wutuh Bisnis MoonLake Immunotherapeutics AG|Crinetics Pharma (CRNX) - Nilai Perusahaan|Nilai Dipunlarasaken Utang lan Kas NewAmsterdam Pharma Corp (NAMS)|Nilai Perusahaan SLNO (Soleno Therapeutics)|amicusrx.com - Nilai Perusahaan|Nilai Total Perusahaan 89bio (ETNB)|AGIO: Nilai Dipunlarasaken Utang lan Kas|GPCR (Structure Pharma) - Nilai Total Perusahaan|MiMedx Corp (MDXG) - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|RZLT (Rezolute, Inc.) - Nilai Perusahaan|Nilai Perusahaan lexpharma.com (LXRX)|MBX Biosciences (MBX) - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|Nilai Dipunlarasaken Utang lan Kas ALT (Altimmune Inc)|Aardvark Therapeutics Corp - Nilai Total Perusahaan|Rega Nyata Tumbas Perusahaan Kanthi Wutuh Sagimet Biosciences Inc SGMT|BMEA (Biomea Fusion, Inc.) - Nilai Perusahaan|Quince Therapeutics (QNCX) - Total Nilai Perusahaan|GUTS - Rega Nyata Tumbas Perusahaan Kanthi Wutuh|vTv Therapeutics (VTVT) - Total Nilai Bisnis|ATPC (Agape ATP Corp) - Nilai Perusahaan|Nilai Perusahaan Pluri Inc|Nilai Perusahaan Synlogic, Inc. (SYBX)|Nilai Total Perusahaan LPCN (lipocine.com)|MTNB: Nilai Total Perusahaan|sprucebiosciences.com - Total Nilai Perusahaan|GLTO - Nilai Total Perusahaan|CTCX - Nilai Total Perusahaan|Lumos Pharma, Inc. - Nilai Perusahaan|ONVO (organovo.com) - Rega Tumbas Perusahaan|RDUS: Nilai Total Perusahaan